14.72MMarket Cap-564P/E (TTM)
1.6100High1.3800Low338.22KVolume1.4100Open1.3600Pre Close513.37KTurnover7.05%Turnover RatioLossP/E (Static)9.47MShares3.550052wk High-0.50P/B7.46MFloat Cap1.050952wk Low--Dividend TTM4.79MShs Float143.4487Historical High--Div YieldTTM16.91%Amplitude1.0500Historical Low1.5170Avg Price1Lot Size
Trinity Biotech Stock Forum
Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology
Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology
DUBLIN, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the successful completion of its first pre-pivotal clinical trial in Europe for its next-generation continuous glucos...
Trinity Biotech Announces Acquisition Of Metabolomics Diagnostics, Co Has Developed An Innovative Test, PrePsia, To Accurately Predict The Risk Of Preeclampsia In Pregnant Women
-Metabolomics Diagnostics, a deep-tech m
https://www.moomoo.com/t/news/post/43866450/mNmrMuMQ2b
tipranks.com/ne...
https://www.investing.com/news/assorted/trinity-biotech-to-initiate-cgm-market-study-in-india-432SI-3622090
Trinity Biotech to Initiate Cgm Market Study in India in Furtherance of Intended Collaboration With Bayer
No comment yet